A 30-item exam in powerpoint on Normal OB Nursing. Includes objective and situational questions. Without answers or rationale.Full description
Maternal and Child Health nursing, very informative bullets
summarized concepts in maternal health nursing
Complete compilation of OB lecture notesFull description
ob
Full description
Complete compilation of OB lecture notes
big OB-vanFull description
Maternal and Child Care
5Full description
Medications: Postpartum
Classification, Action, & Use
Dose & Route
Side Effects & Adverse Reactions
Contraindications & Precautions
Nursing Considerations & Patient Teaching
DepoProvera
Progestin contraceptives. Provides highly effective birth control for three months when administered every 3 months.
IM injection of 150 mg
Menstrual irregularities, headache, weight gain, breast tenderness, depression, severe chest pain, leg pain, abdominal pain. Return of fertility may be delayed for an average of nine months.
Do not use if pregnant and caution with breastfeeding. Undiagnosed abnormal vaginal bleeding; history of or current thrombophlebitis thrombophlebitis or venous thromboembolic disorders (including DVT, PE); active or recent (within 1 year) arterial thromboembolic disease (eg, stroke, MI); carcinoma of the breast; estrogen-dependent tumor; hepatic dysfunction or disease; pregnancy
Nurse makes sure sure that patient has chosen the best method of contraception. Provide accurate accurate information in a non judgmental way, focus on open discussion, provide written handout identifying the warning signs and the actions a women should take. Teach to get injection every 3 months. Depo does not protect against STD’s - need to use a barrier method for STD protection. Prolonged use may result in the loss of bone mineral density (BMD). The warning specifically applies to the use of medroxyprogesterone medroxyprogesterone contraceptive injection. Bone density loss is related to the duration of use, and may not be completely reversible on discontinuation of the drug. The impact on peak bone mass in adolescents, adolescents, as well well as the loss of BMD which accompanies pregnancy and lactation, should be considered in treatment decisions. Longterm use (ie, >2 years) should be limited to situations where other birth control methods are inadequate.